Intco Medical Technology Co Ltd
SZSE:300677
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intco Medical Technology Co Ltd
SZSE:300677
|
CN |
|
Texas Instruments Inc
NASDAQ:TXN
|
US |
Balance Sheet
Balance Sheet Decomposition
Intco Medical Technology Co Ltd
Intco Medical Technology Co Ltd
Balance Sheet
Intco Medical Technology Co Ltd
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
94
|
60
|
104
|
287
|
549
|
615
|
5 009
|
4 980
|
5 022
|
4 807
|
3 298
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4 980
|
4 995
|
4 807
|
3 298
|
|
| Cash Equivalents |
94
|
60
|
104
|
287
|
549
|
614
|
5 008
|
0
|
28
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
258
|
1 381
|
3 274
|
3 237
|
5 960
|
6 755
|
|
| Total Receivables |
153
|
174
|
222
|
241
|
351
|
398
|
700
|
1 152
|
749
|
1 128
|
1 662
|
|
| Accounts Receivables |
126
|
163
|
207
|
236
|
314
|
332
|
517
|
775
|
554
|
922
|
1 363
|
|
| Other Receivables |
27
|
11
|
15
|
5
|
37
|
66
|
183
|
377
|
195
|
205
|
299
|
|
| Inventory |
68
|
79
|
141
|
162
|
207
|
233
|
847
|
1 079
|
1 004
|
1 150
|
1 265
|
|
| Other Current Assets |
17
|
10
|
17
|
165
|
334
|
41
|
572
|
278
|
224
|
2 559
|
8 975
|
|
| Total Current Assets |
332
|
323
|
484
|
855
|
1 441
|
1 544
|
8 510
|
10 763
|
10 235
|
15 603
|
21 955
|
|
| PP&E Net |
301
|
406
|
641
|
764
|
881
|
1 210
|
3 865
|
8 477
|
9 290
|
9 437
|
9 885
|
|
| PP&E Gross |
301
|
406
|
0
|
764
|
881
|
1 210
|
3 865
|
8 477
|
9 290
|
9 437
|
9 885
|
|
| Accumulated Depreciation |
77
|
103
|
0
|
199
|
271
|
360
|
486
|
735
|
1 311
|
1 985
|
2 718
|
|
| Intangible Assets |
19
|
21
|
32
|
32
|
92
|
195
|
349
|
630
|
583
|
567
|
767
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
4
|
34
|
34
|
491
|
1 280
|
1 406
|
1 939
|
|
| Other Long-Term Assets |
4
|
4
|
6
|
7
|
8
|
9
|
177
|
264
|
90
|
66
|
86
|
|
| Total Assets |
657
N/A
|
754
+15%
|
1 164
+54%
|
1 658
+42%
|
2 425
+46%
|
2 992
+23%
|
12 935
+332%
|
20 625
+59%
|
21 479
+4%
|
27 079
+26%
|
34 631
+28%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
107
|
107
|
154
|
169
|
154
|
226
|
639
|
1 192
|
946
|
922
|
845
|
|
| Accrued Liabilities |
12
|
13
|
19
|
30
|
27
|
31
|
86
|
108
|
148
|
119
|
151
|
|
| Short-Term Debt |
325
|
188
|
383
|
273
|
834
|
534
|
239
|
96
|
1 494
|
7 034
|
12 666
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
17
|
28
|
37
|
33
|
55
|
436
|
|
| Other Current Liabilities |
25
|
24
|
28
|
54
|
57
|
60
|
1 236
|
650
|
534
|
488
|
584
|
|
| Total Current Liabilities |
469
|
333
|
584
|
527
|
1 073
|
868
|
2 228
|
2 084
|
3 155
|
8 618
|
14 683
|
|
| Long-Term Debt |
17
|
0
|
37
|
33
|
44
|
535
|
230
|
205
|
53
|
77
|
167
|
|
| Deferred Income Tax |
0
|
0
|
7
|
10
|
12
|
28
|
966
|
2 012
|
2 093
|
1 965
|
1 944
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
24
|
99
|
252
|
243
|
266
|
278
|
|
| Other Liabilities |
2
|
6
|
0
|
1
|
23
|
59
|
68
|
201
|
129
|
124
|
156
|
|
| Total Liabilities |
488
N/A
|
339
-31%
|
628
+85%
|
571
-9%
|
1 152
+102%
|
1 515
+32%
|
3 591
+137%
|
4 753
+32%
|
5 672
+19%
|
11 051
+95%
|
17 227
+56%
|
|
| Equity | ||||||||||||
| Common Stock |
58
|
73
|
73
|
98
|
196
|
198
|
352
|
550
|
660
|
656
|
646
|
|
| Retained Earnings |
19
|
81
|
160
|
305
|
469
|
618
|
7 481
|
13 859
|
14 082
|
14 409
|
15 786
|
|
| Additional Paid In Capital |
93
|
261
|
301
|
707
|
618
|
638
|
1 586
|
1 509
|
1 310
|
1 287
|
1 114
|
|
| Treasury Stock |
0
|
0
|
0
|
23
|
14
|
23
|
72
|
28
|
254
|
321
|
133
|
|
| Other Equity |
1
|
0
|
2
|
1
|
3
|
46
|
2
|
19
|
9
|
2
|
8
|
|
| Total Equity |
168
N/A
|
415
+147%
|
535
+29%
|
1 088
+103%
|
1 273
+17%
|
1 477
+16%
|
9 344
+533%
|
15 871
+70%
|
15 806
0%
|
16 029
+1%
|
17 404
+9%
|
|
| Total Liabilities & Equity |
657
N/A
|
754
+15%
|
1 164
+54%
|
1 658
+42%
|
2 425
+46%
|
2 992
+23%
|
12 935
+332%
|
20 625
+59%
|
21 479
+4%
|
27 079
+26%
|
34 631
+28%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
175
|
219
|
219
|
292
|
293
|
293
|
347
|
657
|
647
|
645
|
646
|
|